GAPcareII: The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department II

Sponsor
Rhode Island Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04304495
Collaborator
National Institute on Aging (NIA) (NIH), Apple Inc. (Industry)
200
2
2
48
100
2.1

Study Details

Study Description

Brief Summary

In brief, this K76 study consists of a small open trial to refine the study protocol and train study personnel on study procedures (Aim 1.b.). In Aim 2, we will recruit older adults into a multidisciplinary fall prevention pilot study. Participants will be randomly assigned to usual care with a traditional fall evaluation by an ED clinician (i.e., ED medical staff member) or an intervention. In the intervention, participants will receive an in-ED consultation by a physical therapist and pharmacist to determine reasons for the fall and offer additional education and training. Participants will be provided an Apple Watch to record measures of fitness and falls, if possible, in the following 12 months. Recurrent falls will be measured in twelve-month follow-up.

Condition or Disease Intervention/Treatment Phase
  • Other: Fall Prevention
N/A

Detailed Description

In order to determine whether a multifactorial fall prevention intervention is feasible, acceptable and may reduce recurrent falls in older adults presenting to the ED after a fall, we will randomize patients to usual care with a traditional fall evaluation by an ED clinician or an intervention. Patients in the intervention arm receive a fall risk assessment and recommendations by a physical therapist. They are also evaluated by a pharmacist and participate in a medication therapy management session with the aim to reduce fall risk increasing medication.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Participants will be randomly assigned (by the REDCap program) 1:1 to the intervention or usual care arm.
Primary Purpose:
Prevention
Official Title:
GAPcare II: The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department
Actual Study Start Date :
Aug 2, 2021
Anticipated Primary Completion Date :
Aug 2, 2024
Anticipated Study Completion Date :
Aug 2, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

In addition to the usual care arm, the Intervention arm will receive a physical therapy and pharmacy consultation in the ED. PTs will perform a fall risk assessment and provide recommendations on the safety of discharge. Pharmacists will perform medication review, recommend cessation or tapering of medication that increase fall risk using motivational interviewing (MTM) techniques. The participants will also receive Apple Watch training and an Apple Watch to perform tasks that test their memory and mobility during their ED visit and during our home visits at 1,3, 6, and 12 month after enrollment.

Other: Fall Prevention
The intervention arm participants will receive a physical therapy and pharmacy consults as well as Apple Watch training and an Apple Watch device to test memory and mobility during the ED visit and during our home visits.

No Intervention: Usual care arm

The ED clinician will perform a standard medical evaluation, including a focused history and exam to identify injuries, laboratory tests and radiologic imaging. If necessary, the patient will receive consultation with specialty services (e.g., orthopedics). The participants will also receive Apple Watch training and an Apple Watch to perform tasks that test their memory and mobility during their ED visit and during our home visits at 1,3, 6, and 12 month after enrollment.

Outcome Measures

Primary Outcome Measures

  1. Rate of study activity completion [12 months]

    Rate of participants who completed all study activities, including initial enrollment and multiple follow up visits over a 12 month period

Secondary Outcome Measures

  1. Change in gait speed [12 months]

    Apple watch determined; average change in gait speed over 12-month follow-up

  2. Change in activity level [12 months]

    Apple watch determined; average change in proportion of time spent active per day (e.g. walking, running, not driving or sedentary)

  3. Number of recurrent falls [12 months]

    Number of falls in person months

  4. Number of ED re-visits [12 months]

    Any visit to the ED in the 12-month follow-up

  5. Rate of hospitalization [12 months]

    Any hospital admission in the 12-month follow-up

  6. Rate of permanent moves to nursing homes [12 months]

    Any move to a nursing home for >30 days

  7. Mortality rate [12 months]

    All cause patient mortality in follow-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Community-dwelling adult (non-institutionalized) 65 years-old or older presenting to ED after a fall

  • Fall not due to syncope or external force (i.e., struck by car or assault)

  • Fall not due to serious illness (i.e., stroke, acute myocardial infarction)

  • Will be discharged to home/assisted living/rehabilitation at completion of ED visit (i.e., not admitted)

  • Legally authorized representative able to give informed consent if patient has cognitive impairment on Six Item Screener (score of less than four) either over the phone with witness present or in person

  • Must screen or test negative for COVID-19

Exclusion Criteria:
  • Unable to give informed consent due to intoxication or altered mental status

  • Presence of injuries that prevent mobilization (i.e., pelvic or lower extremity fractures)

  • Allergies to any wearable device component

  • Unable or unwilling to wear Apple Watch at home (only for periodic study visits)

  • Patient has advanced cancer and/or is on hospice care

  • Pts coming from SNF or nursing home

  • Previously enrolled in GAPcare II Aim1.b

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rhode Island Hospital Providence Rhode Island United States 02903
2 The Miriam Hospital Providence Rhode Island United States 02906

Sponsors and Collaborators

  • Rhode Island Hospital
  • National Institute on Aging (NIA)
  • Apple Inc.

Investigators

  • Principal Investigator: Elizabeth M Goldberg, MD, ScM, Brown University; Lifespan Health System

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT04304495
Other Study ID Numbers:
  • K76AG059983
  • K76AG059983
First Posted:
Mar 11, 2020
Last Update Posted:
Sep 22, 2021
Last Verified:
Apr 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rhode Island Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2021